425: Strive CFO Reposts Semler Scientific Merger Update

Strive's CFO reposted a communication on X.com regarding the proposed business combination with Semler Scientific, emphasizing forward-looking statements and regulatory filings.

Summary

• A communication was reposted on X.com by Ben Pham, Chief Financial Officer of Strive, Inc., on November 10, 2025.
• The communication pertains to Strive's proposed business combination with Semler Scientific, Inc.
• It contains forward-looking statements regarding the outlook, expectations, strategic and financial benefits, timing of closing, and successful integration of the combined businesses.
• The filing highlights inherent risks and uncertainties associated with the proposed transaction, including potential termination, failure to close, legal proceedings, unrealized benefits (including those related to Bitcoin treasury strategies and digital assets), integration difficulties, unexpected costs, management distraction, dilution, adverse customer/employee reactions, and share price changes.
• Investors are urged to read the Registration Statement on Form S-4, which includes an Information Statement/Proxy Statement/Prospectus, and other relevant SEC documents before making voting or investment decisions.
• Strive, Semler Scientific, and their respective directors, executive officers, and employees may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.
• The communication explicitly states it does not constitute an offer to sell or solicit securities.

Sentiment

Score: 5

Explanation: The filing is neutral in tone, primarily a legal disclosure about a proposed merger and its associated risks, rather than a positive or negative operational update. It serves to inform stakeholders about the ongoing process and inherent uncertainties.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all, potentially due to changes in or problems arising from the implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, laws and regulations, and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The outlook and expectations of Strive and Semler Scientific are focused on the proposed business combination, including anticipated strategic and financial benefits, the timing of the closing of the transaction, and the ability to successfully integrate the combined businesses.

Management Comments

• Although each of Strive and Semler Scientific believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations, there can be no assurance that actual results of Strive or Semler Scientific will not differ materially from any projected future results expressed or implied by such forward-looking statements.
• Strive and Semler Scientific undertake no obligation to update or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable law.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that the combined entity may be engaging in or planning to engage in digital asset management, a growing but volatile area for corporate treasuries. Semler Scientific's involvement implies a potential strategic shift or expansion for a company typically associated with healthcare, aligning with broader trends of companies exploring new asset classes or business models.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for dilution due to Strive's issuance of additional Class A common stock; required to vote on the proposed transaction; potential impact on share price.
• Customers: Potential for adverse reactions or changes to business relationships as a result of the announcement or completion of the proposed transaction.
• Employees: Potential for adverse reactions or changes to employee relationships as a result of the announcement or completion of the proposed transaction.

Next Steps

• Strive will file a definitive Information Statement/Proxy Statement/Prospectus with the SEC.
• Semler Scientific stockholders will be sent the definitive Information Statement/Proxy Statement/Prospectus to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with any other relevant documents filed with the SEC.

Key Dates

Recommendation

The filing is a cautionary statement regarding a proposed business combination, outlining numerous risks and forward-looking statements without providing new financial performance metrics. While a merger can be a catalyst, the emphasis on potential integration difficulties, dilution, and risks related to Bitcoin treasury strategies suggests a 'hold' position until more definitive information, particularly the full Information Statement/Proxy Statement/Prospectus, is available for a comprehensive assessment of the combined entity's prospects and valuation.

Keywords

Merger, Business Combination, Strive Inc, Semler Scientific Inc, SEC Filing, Forward-Looking Statements, Bitcoin Treasury, Digital Assets, Corporate Governance, Proxy Solicitation